# 116-hr-6930: MADE in America Act of 2020

116-hr-6930, MADE in America Act of 2020, is a 116th Congress bill sponsored by Rep. Carter, Earl L. "Buddy" [R-GA-1] (R-GA); status Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (as of 2025-11-18).

- Canonical: https://policyrisk.com/legislation/116-hr-6930
- As of: 2025-11-18
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 116-hr-6930
- Congress: 116
- Title: MADE in America Act of 2020
- Status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced: 2020-05-19
- Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (R-GA)
- Cosponsors: 8
- Policy area: Health
- Touches household money: no
- Last recorded action: 2025-11-18

## Summary

Manufacturing API, Drugs, and Excipients in America Act of 2020 or the MADE in America Act of 2020 This bill establishes a tax credit for taxpayers engaged in medical production activities in certain areas and contains other provisions related to pharmaceuticals. An eligible taxpayer may claim a tax credit equal to 30% of qualified expenditures related to the production of pharmaceuticals, medical devices, or other related items in a designated qualified opportunity zone with a poverty rate higher than 30%. In addition, the Food and Drug Administration shall continue a program to evaluate new drug manufacturing technologies included in an application for approval of a drug or biological product. The bill imposes various requirements on this program, including deadlines for evaluating such a technology. Furthermore, the Department of Health and Human Services shall establish or expand programs to promote regulatory consistency and cooperation with drug regulatory authorities in other countries.

## Cosponsors (8)

- Rep. Griffith, H. Morgan [R-VA-9] (R-VA), 2020-05-19T00:00:00.000Z
- Rep. McKinley, David B. [R-WV-1] (R-WV), 2020-05-19T00:00:00.000Z
- Rep. Crawford, Eric A. "Rick" [R-AR-1] (R-AR), 2020-05-19T00:00:00.000Z
- Rep. Soto, Darren [D-FL-9] (D-FL), 2020-05-19T00:00:00.000Z
- Rep. Westerman, Bruce [R-AR-4] (R-AR), 2020-06-18T00:00:00.000Z
- Rep. Van Drew, Jefferson [R-NJ-2] (R-NJ), 2020-06-18T00:00:00.000Z
- Rep. Cartwright, Matt [D-PA-8] (D-PA), 2020-07-09T00:00:00.000Z
- Rep. Rice, Tom [R-SC-7] (R-SC), 2020-10-01T00:00:00.000Z

## Related bills

- 116-hr-6829: EMPIL–DOC Act
- 116-hr-1570: Removing Barriers to Colorectal Cancer Screening Act of 2020
- 116-hr-1108: Aviation Funding Stability Act of 2019
- 116-hr-550: Merchant Mariners of World War II Congressional Gold Medal Act of 2019
- 116-hr-8662: Accelerating Access to Critical Therapies for ALS Act
- 116-hr-4305: PAWS for Veterans Therapy Act

## Sources
- [116-hr-6930 on Congress.gov](https://www.congress.gov/bill/116th-congress/house-bill/6930)

## Related
- [116-hr-6829: EMPIL–DOC Act](https://policyrisk.com/legislation/116-hr-6829)
- [116-hr-1570: Removing Barriers to Colorectal Cancer Screening Act of 2020](https://policyrisk.com/legislation/116-hr-1570)
- [116-hr-1108: Aviation Funding Stability Act of 2019](https://policyrisk.com/legislation/116-hr-1108)
- [116-hr-550: Merchant Mariners of World War II Congressional Gold Medal Act of 2019](https://policyrisk.com/legislation/116-hr-550)
- [116-hr-8662: Accelerating Access to Critical Therapies for ALS Act](https://policyrisk.com/legislation/116-hr-8662)
- [116-hr-4305: PAWS for Veterans Therapy Act](https://policyrisk.com/legislation/116-hr-4305)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/116-hr-6930 (as of 2025-11-18).